GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference
SAN FRANCISCO, CALIFORNIA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology...
Day: February 17, 2026
Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
European Commission Approval Based on Results of SEQUOIA-HCM First European Launch Expected in Germany in Q2 2026 SOUTH SAN FRANCISCO,...
BridgeBio to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 24, 2026 at 4:30 pm ET
PALO ALTO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical...
Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder
Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive symptoms as...
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50...
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
Company to Focus on Pancreatic Cancer Detection Business in the U.S., Strategic Asset Sales and Future Strategic TransactionBERKELEY, Calif. and...
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
JUPITER, Fla. and ANKENY, Iowa, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the...
Functional Brands Inc. Introduces Kirkman’s(R) Exciting New Restorative Sleep Bundle for Deep, Refreshing Sleep Without Grogginess
A Science-Backed Solution to Support Relaxation and Nervous System BalanceLake Oswego, Oregon--(Newsfile Corp. - February 17, 2026) - Functional Brands...
Safe Supply Announces Sale of Two NIRLAB Drug Analysis Devices Supporting Indigenous-Led Community Safety Initiatives
Toronto, Ontario--(Newsfile Corp. - February 17, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe...
QScreen AI Advances Quantum-Inspired Optimization with U.S. Patent Filing; Gains National Spotlight on CBC
Toronto, Ontario--(Newsfile Corp. - February 17, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator...
Optimi Health Reports First MDMA-Assisted Treatments of 2026 are Underway Across an Expanded Network of Australian Clinics
MDMA-assisted therapy for PTSD delivered through Optimi's direct-to-clinic supply model under Australia's Authorised Prescriber SchemeVancouver, British Columbia--(Newsfile Corp. - February...
Precision AQ expands senior leadership team to strengthen global AI, data strategy, evidence synthesis and economic modelling capabilities
NEW YORK, Feb. 17, 2026 /PRNewswire/ -- Precision AQ, a global commercialisation partner built to guide life science innovators through commercial complexity,...
BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis
VANCOUVER, BC / ACCESS Newswire / February 17, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...
The 3D Printing Industry Has Been Declining for Years. FUGO Precision 3D Was Built to Fix What Caused It.
GARDENA, Calif., Feb. 16, 2026 /PRNewswire/ -- "The additive manufacturing industry has been losing ground for years, and everyone knows...